No protective role of Helicobacter pylori in the pathogenesis of reflux esophagitis in patients with duodenal or benign gastric ulcer in Korea

Digestive Diseases and Sciences

Volumn 46, Issue 12, 2001, Pages 2724-2732

  Kim, Nayoung ^a   Lim, Seon Hee ^a   Lee, Kye Heui ^a  

^a Public Corporation   (South Korea)

Author keywords

Benign gastric ulcer; Duodenal ulcer; Helicobacter pylori; Reflux esophagitis

Indexed keywords

AMOXICILLIN; BISMUTH CITRATE; CLARITHROMYCIN; METRONIDAZOLE; OMEPRAZOLE; TETRACYCLINE;

ADULT; AGED; ARTICLE; DUODENUM ULCER; FEMALE; GASTROINTESTINAL ENDOSCOPY; GASTROINTESTINAL INFECTION; HELICOBACTER PYLORI; HUMAN; INCIDENCE; KOREA; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; REFLUX ESOPHAGITIS; STOMACH ULCER;

ADULT; DUODENAL ULCER; ESOPHAGITIS, PEPTIC; FEMALE; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; KOREA; MALE; MIDDLE AGED; STOMACH ULCER;

EID: 0035195812     PISSN: 01632116     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1012783630913     Document Type: Article

References (64)

1. Schistosomes, liver flukes and Helicobacter pylori
2. Helicobacter pylori in peptic ulcer disease
3. Helicobacter pylori-associated gastritis and primary B-cell gastric lymphoma
4. Helicobacter pylori gastritis and gastric MALT-lymphoma
5. Current European concepts in the management of Helicobacter pylori infection. The Maastricht Concensus Report
6. Current European concepts in the management of Helicobacter pylori, infection - The Maastricht Concensus Report
7. Concensus or confusion: A review of existing natural guidelines on Helicobacter pylori-related disease
8. Helicobacter pylori and gastro-oesophageal reflux disease - A prospective study
9. Treatment of ulcerative reflux oesophagitis with colloidal bismuth subcitrate in combination with cimetidine
10. Patterns of colonisation of Campylobacter pylori, in the oesophagus, stomach and duodenum
11. Prevalence of Campylobacter pylori in esophagitis, gastritis and duodenal disease
12. Evaluation of Helicobacter pylori in reflux oesophagitis and Barrett's oesophagus
13. Helicobacter pylori in 205 consecutive endoscopy patients
14. Reflux oesophagitis and Helicobacter pylori infection in elderly patients
15. Association of infection due to Helicobacter pylori with specific upper gastrointestinal pathology
16. Negative association between Helicobacter pylori infection and reflux esophagitis in older patients: Case-control study in Japan
17. Gastric mucosal atrophy and prevalence of Helicobacter pylori in reflux oesophagitis of the elderly
18. Helicobacter pylori infection has no role in the pathogenesis of reflux esophagitis
19. Helicobacter pylori reinfection with identical organisms: Transmission by the patients' spouses
20. Long-term consequences of Helicobacter pylori eradication: Clinical aspects
21. Curing Helicobacter pylori infection in patients with duodenal ulcer may provoke reflux esophagitis
22. Reflux esophagitis: A complication of Helicobacter pylori (HP) eradication therapy
23. Changes in the intragastric distribution of Helicobacter pylori during treatment with omeprazole
24. Atrophic gastritis and Helicobacter pylori infection in patients with reflux esophagitis treated with omeprazole or fundoplication
25. Long term omeprazole therapy in peptic ulcer disease: Gastrin, endocrine cell growth and gastritis
26. Helicobacter pylori gastritis and epithelial cell proliferation in patients with reflux oesophagitis after treatment with lansoprazole
27. Gastritis development and acid suppression therapy revisited. Results of a randomised clinical study with long-term follow-up
28. The natural history, prevalence and incidence of reflux esophagitis
29. Relationship of hiatus hernia to reflux oesophagitis. A prospective study of coincidence, using endoscopy
30. A new endoscopic classification of chronic esophagitis
31. Are clinical patterns of dyspepsia a valid guideline for appropriate use of endoscopy? A report on 2253 dyspeptic patients
32. Endoscopic findings and diagnoses in unselected dyspeptic patients at a primary health care center
33. The incidence of reflux-esophagitis among the Chinese
34. Diagnosis of early esophageal cancer
35. Epidemiologic study of reflux esophagitis in general health screening people
36. The prevalence and risk factors of reflux esophagitis in routine check-up subjects
37. Erosive esophagitis and Barrett's esophagus in Taiwan - A higher frequency than expected
38. Helicobacter pylori and peptic ulceration: Histopathological aspects
39. Chronic gastritis and gastroduodenal ulcer: A case control study on risk of coexisting duodenal or gastric ulcer in patients with gastritis
40. Identifying persons at risk for gastric cancer?
41. Savary-Miller's new endoscopic grading of reflux-oesophagitis: A simple, reproducible, logical, complete and useful classification
42. Early diagnosis of columnar-lined esophagus. A new endoscopic diagnostic criterion
43. Long-term effects of Helicobacter pylori eradication on intestinal metaplasia in patients with duodenal and benign gastric ulcers
44. Classification and grading of gastritis: The updated Sydney system
45. Helicobacter pylori infection and chronic gastric acid hyposecretion
46. Gastroesophageal reflux. Pathogenesis, diagnosis, and therapy
47. Symptoms and endoscopic findings in diagnosis of gastroesophageal reflux disease
48. Mechanisms of gastroesophageal reflux in patients with reflux esophagitis
49. Mechanisms of lower oesophageal sphincter incompetence in patients with symptomatic gastroesophageal reflux
50. Esophageal peristaltic dysfunction in peptic esophagitis
51. Clinical and manometric findings in benign peptic strictures of the esophagus
52. The relationship between control of pH and healing and symptom relief in gastro-oesophageal reflux disease
53. Corpus gastritis is protective against reflux oesophagitis
54. Helicobacter pylori infection and abnormalities of acid secretion in patients with duodenal ulcer disease
55. Correlative study: Gastric secretion and histology
56. The relationship between acid secretion after augmented histamine stimulation and histology of gastric mucosa
57. Cure of Helicobacter pylori infection improves gastric acid secretion in patients with corpus gastritis
58. Omeprazole coupled with two antibiotics for Helicobacter pylori eradication and prevention of ulcer recurrence
59. The role of Campylobacter pylori in gastroduodenal diseases. A "believer"'s point of view. First Meeting of the European Campylobacter pylori Study Group. Bordeaux 1988
60. Campylobacter pylori and peptic ulcer disease
61. H. pylori and gastroesophageal reflux disease: Lack of influence of infection on pH-metric and endoscopic findings
62. The effect of the eradication of Helicobacter pylori on the patients with duodenal ulcer recurrence. A 24 month follow-up study
63. The role of Helicobacter pylori and NSAID in patients with benign gastric ulcer